Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines in Southern Africa has been steadily increasing in recent years.
Customer preferences: Southern Africa has a high prevalence of infectious diseases, such as HIV/AIDS, malaria, and tuberculosis. As a result, there is a growing demand for vaccines to prevent these diseases. Additionally, there is an increasing awareness of the importance of vaccines in preventing the spread of infectious diseases, which has led to more people seeking vaccination.
Trends in the market: One of the main trends in the vaccines market in Southern Africa is the increasing availability of vaccines. Governments in the region are investing in healthcare infrastructure and working with international organizations to improve access to vaccines. This has led to a greater number of vaccines being available in the market, which has increased competition and driven down prices.Another trend is the growing demand for new vaccines. With the rise of infectious diseases and the threat of pandemics, there is a need for new vaccines to be developed. This has led to increased investment in research and development of new vaccines, which has resulted in the introduction of new vaccines into the market.
Local special circumstances: One of the unique challenges in the Southern Africa region is the lack of access to healthcare in rural areas. Many people in these areas do not have access to healthcare facilities, which makes it difficult for them to receive vaccines. To address this issue, governments and international organizations are working to improve healthcare infrastructure in rural areas and provide mobile clinics to reach remote populations.
Underlying macroeconomic factors: The Southern Africa region has experienced economic growth in recent years, which has led to an increase in healthcare spending. This has allowed governments to invest in healthcare infrastructure and improve access to vaccines. Additionally, the region has a young and growing population, which has increased the demand for vaccines. As the population continues to grow, the demand for vaccines is expected to increase further.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
